Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$0.62 - $0.85 $248 - $340
-400 Reduced 12.37%
2,834 $2,000
Q4 2023

Feb 14, 2024

SELL
$0.67 - $1.35 $670 - $1,351
-1,001 Reduced 23.64%
3,234 $2,000
Q3 2023

Nov 09, 2023

SELL
$1.02 - $1.23 $2,144 - $2,585
-2,102 Reduced 33.17%
4,235 $4,000
Q2 2023

Aug 09, 2023

SELL
$1.04 - $1.4 $9,378 - $12,625
-9,018 Reduced 58.73%
6,337 $7,000
Q1 2023

May 12, 2023

BUY
$1.15 - $1.89 $17,658 - $29,020
15,355 New
15,355 $21,000
Q3 2022

Nov 09, 2022

SELL
$1.33 - $2.6 $53,450 - $104,488
-40,188 Reduced 47.79%
43,905 $72,000
Q2 2022

Aug 11, 2022

BUY
$0.67 - $1.4 $7,414 - $15,492
11,066 Added 15.15%
84,093 $110,000
Q1 2022

May 12, 2022

BUY
$1.23 - $3.31 $21,146 - $56,905
17,192 Added 30.79%
73,027 $90,000
Q4 2021

Feb 11, 2022

BUY
$2.89 - $4.43 $161,363 - $247,349
55,835 New
55,835 $182,000
Q3 2021

Nov 12, 2021

SELL
$3.36 - $4.62 $279,555 - $384,388
-83,201 Closed
0 $0
Q2 2021

Aug 10, 2021

BUY
$2.82 - $5.01 $146,143 - $259,638
51,824 Added 165.17%
83,201 $348,000
Q1 2021

May 12, 2021

BUY
$2.92 - $5.07 $51,009 - $88,567
17,469 Added 125.6%
31,377 $142,000
Q4 2020

Feb 10, 2021

SELL
$1.64 - $3.42 $6,476 - $13,505
-3,949 Reduced 22.11%
13,908 $42,000
Q3 2020

Nov 12, 2020

SELL
$2.18 - $2.84 $76,862 - $100,132
-35,258 Reduced 66.38%
17,857 $44,000
Q2 2020

Aug 13, 2020

BUY
$1.83 - $4.06 $23,456 - $52,041
12,818 Added 31.81%
53,115 $151,000
Q1 2020

May 13, 2020

BUY
$1.5 - $4.52 $60,445 - $182,142
40,297 New
40,297 $97,000
Q3 2019

Nov 12, 2019

SELL
$1.6 - $2.08 $6,000 - $7,800
-3,750 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$1.47 - $3.06 $3,166 - $6,591
2,154 Added 134.96%
3,750 $9,000
Q4 2018

Feb 06, 2019

BUY
$2.66 - $15.93 $3,226 - $19,323
1,213 Added 316.71%
1,596 $4,000
Q3 2018

Nov 08, 2018

BUY
$12.07 - $16.0 $4,622 - $6,128
383 New
383 $6,000

Others Institutions Holding SELB

About SELECTA BIOSCIENCES INC


  • Ticker SELB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 152,712,992
  • Market Cap $128M
  • Description
  • Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...
More about SELB
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.